Cargando…

Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas

BACKGROUND: Glucose tolerance (GT) has not been taken into consideration in investigations concerning relationships between coagulopathy and multiple organ dysfunction syndrome (MODS), and endothelial cell activation/endothelial cell injury (ECA/ECI) in septic patients, although coagulopathy is know...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoshino, Masami, Haraguchi, Yoshikura, Hirasawa, Hiroyuki, Sakai, Motohiro, Saegusa, Hiroshi, Hayashi, Kazushiro, Horita, Naoki, Ohsawa, Hiroyuki
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC30714/
https://www.ncbi.nlm.nih.gov/pubmed/11299067
_version_ 1782119972866097152
author Hoshino, Masami
Haraguchi, Yoshikura
Hirasawa, Hiroyuki
Sakai, Motohiro
Saegusa, Hiroshi
Hayashi, Kazushiro
Horita, Naoki
Ohsawa, Hiroyuki
author_facet Hoshino, Masami
Haraguchi, Yoshikura
Hirasawa, Hiroyuki
Sakai, Motohiro
Saegusa, Hiroshi
Hayashi, Kazushiro
Horita, Naoki
Ohsawa, Hiroyuki
author_sort Hoshino, Masami
collection PubMed
description BACKGROUND: Glucose tolerance (GT) has not been taken into consideration in investigations concerning relationships between coagulopathy and multiple organ dysfunction syndrome (MODS), and endothelial cell activation/endothelial cell injury (ECA/ECI) in septic patients, although coagulopathy is known to be influenced by blood glucose level. We investigated those relationships under strict blood glucose control and evaluation of GT with the glucose clamp method by means of the artificial pancreas in nine septic patients with glucose intolerance. The relationships between GT and blood stress related hormone levels (SRH) were also investigated. METHODS: The amount of metabolized glucose (M value), as the parameter of GT, was measured by the euglycemic hyperinsulinemic glucose clamp method, in which the blood glucose level was clamped at 80 mg/dl under a continuous insulin infusion rate of 1.12 mU/kg per min, using the artificial pancreas, STG-22. Multiple organ failure (MOF) score was calculated using the MOF criteria of Japanese Association for Critical Care Medicine. Regarding coagulopathy, the following parameters were used: disseminated intravascular coagulation (DIC) score (calculated from the DIC criteria of the Ministry of Health and Welfare of Japan) and the parameters used for calculating DIC score, protein-C, protein-S, plasminogen, antithrombin III (AT-III), plasminogen activator inhibitor-1 (PAI-1), and tissue plasminogen activator-PAI-1 (tPA-PAI-1) complex. Thrombomodulin (TM) was measured as the indicator of ECI. RESULTS: There were no significant correlations between M value and SRH, parameters indicating coagulopathy and the MOF score. The MOF score and blood TM levels were positively correlated with DIC score, thrombin-AT-III complex and tPA-PAI-1 complex, and negatively correlated with blood platelet count. CONCLUSIONS: GT was not significantly related to SRH, coagulopathy and MODS under strict blood glucose control. Hypercoagulability was closely related to MODS and ECI. Among the parameters indicating coagulopathy, tPA-PAI-1 complex, which is considered to originate from ECA, seemed to be a sensitive parameter of MODS and ECI, and might be a predictive marker of MODS. The treatment for reducing hypercoagulability and ECA/ECI were thought to be justified as one of the therapies for acutely ill septic patients.
format Text
id pubmed-30714
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-307142001-04-17 Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas Hoshino, Masami Haraguchi, Yoshikura Hirasawa, Hiroyuki Sakai, Motohiro Saegusa, Hiroshi Hayashi, Kazushiro Horita, Naoki Ohsawa, Hiroyuki Crit Care Primary Research BACKGROUND: Glucose tolerance (GT) has not been taken into consideration in investigations concerning relationships between coagulopathy and multiple organ dysfunction syndrome (MODS), and endothelial cell activation/endothelial cell injury (ECA/ECI) in septic patients, although coagulopathy is known to be influenced by blood glucose level. We investigated those relationships under strict blood glucose control and evaluation of GT with the glucose clamp method by means of the artificial pancreas in nine septic patients with glucose intolerance. The relationships between GT and blood stress related hormone levels (SRH) were also investigated. METHODS: The amount of metabolized glucose (M value), as the parameter of GT, was measured by the euglycemic hyperinsulinemic glucose clamp method, in which the blood glucose level was clamped at 80 mg/dl under a continuous insulin infusion rate of 1.12 mU/kg per min, using the artificial pancreas, STG-22. Multiple organ failure (MOF) score was calculated using the MOF criteria of Japanese Association for Critical Care Medicine. Regarding coagulopathy, the following parameters were used: disseminated intravascular coagulation (DIC) score (calculated from the DIC criteria of the Ministry of Health and Welfare of Japan) and the parameters used for calculating DIC score, protein-C, protein-S, plasminogen, antithrombin III (AT-III), plasminogen activator inhibitor-1 (PAI-1), and tissue plasminogen activator-PAI-1 (tPA-PAI-1) complex. Thrombomodulin (TM) was measured as the indicator of ECI. RESULTS: There were no significant correlations between M value and SRH, parameters indicating coagulopathy and the MOF score. The MOF score and blood TM levels were positively correlated with DIC score, thrombin-AT-III complex and tPA-PAI-1 complex, and negatively correlated with blood platelet count. CONCLUSIONS: GT was not significantly related to SRH, coagulopathy and MODS under strict blood glucose control. Hypercoagulability was closely related to MODS and ECI. Among the parameters indicating coagulopathy, tPA-PAI-1 complex, which is considered to originate from ECA, seemed to be a sensitive parameter of MODS and ECI, and might be a predictive marker of MODS. The treatment for reducing hypercoagulability and ECA/ECI were thought to be justified as one of the therapies for acutely ill septic patients. BioMed Central 2001 2001-02-26 /pmc/articles/PMC30714/ /pubmed/11299067 Text en Copyright © 2001 Hoshino et al, licensee BioMed Central Ltd
spellingShingle Primary Research
Hoshino, Masami
Haraguchi, Yoshikura
Hirasawa, Hiroyuki
Sakai, Motohiro
Saegusa, Hiroshi
Hayashi, Kazushiro
Horita, Naoki
Ohsawa, Hiroyuki
Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
title Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
title_full Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
title_fullStr Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
title_full_unstemmed Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
title_short Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
title_sort close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC30714/
https://www.ncbi.nlm.nih.gov/pubmed/11299067
work_keys_str_mv AT hoshinomasami closerelationshipoftissueplasminogenactivatorplasminogenactivatorinhibitor1complexwithmultipleorgandysfunctionsyndromeinvestigatedbymeansoftheartificialpancreas
AT haraguchiyoshikura closerelationshipoftissueplasminogenactivatorplasminogenactivatorinhibitor1complexwithmultipleorgandysfunctionsyndromeinvestigatedbymeansoftheartificialpancreas
AT hirasawahiroyuki closerelationshipoftissueplasminogenactivatorplasminogenactivatorinhibitor1complexwithmultipleorgandysfunctionsyndromeinvestigatedbymeansoftheartificialpancreas
AT sakaimotohiro closerelationshipoftissueplasminogenactivatorplasminogenactivatorinhibitor1complexwithmultipleorgandysfunctionsyndromeinvestigatedbymeansoftheartificialpancreas
AT saegusahiroshi closerelationshipoftissueplasminogenactivatorplasminogenactivatorinhibitor1complexwithmultipleorgandysfunctionsyndromeinvestigatedbymeansoftheartificialpancreas
AT hayashikazushiro closerelationshipoftissueplasminogenactivatorplasminogenactivatorinhibitor1complexwithmultipleorgandysfunctionsyndromeinvestigatedbymeansoftheartificialpancreas
AT horitanaoki closerelationshipoftissueplasminogenactivatorplasminogenactivatorinhibitor1complexwithmultipleorgandysfunctionsyndromeinvestigatedbymeansoftheartificialpancreas
AT ohsawahiroyuki closerelationshipoftissueplasminogenactivatorplasminogenactivatorinhibitor1complexwithmultipleorgandysfunctionsyndromeinvestigatedbymeansoftheartificialpancreas